NCT00534859View on ClinicalTrials.gov

PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

March 31, 2011

Conditions
Patients Undergoing High Risk PCI.
Interventions
DEVICE

High Risk PCI

High Risk Percutaneous Coronary Intervention

Trial Locations (10)

10032

Columbia Presbyterian Hospital, New York

15213

UPMC Presbyterian Hospital, Pittsburgh

48073

William Beaumont, Royal Oak

90048

Cedars-Sinai Medical Center, Los Angeles

92037

Scripps, La Jolla

777030

Texas Heart, Houston

02114

Mass General Hospital, Boston

02115

Brigham & Womens, Boston

10029-6574

Mt. Sinai School of Medicine, New York

Unknown

Academic Medical Center, Amsterdam

Sponsors

Lead Sponsor

Abiomed Inc.
All Listed Sponsors
lead

Abiomed Inc.

INDUSTRY